Vincenzo Solfrizzi (Bari, 1961) is a medical doctor with a Ph.D. in Carcinogenesis, Aging, and Immunoregulation, grant supported by the European Community. In 2013, he qualified as an Associate Professor in Geriatric Medicine at the School of Medicine of the University of Bari, where he directed the neuropsychogeriatrics unit from 2011. His main areas of research are predementia syndromes and the cognitive decline of degenerative (Alzheimer’s disease, AD) or vascular origin (vascular dementia) and their relationship with vascular risk factors, genetics, and the Mediterranean diet. He has published more than 200 hundred peer-reviewed scientific papers (h-index 43), collaborating since 2003 with the Department of Neurology, Mayo Clinic, Scottsdale (AZ), USA, and since 2008 with the Pasteur Institute of Lille Epidemiology and Public Health Unit for issues related to the genetics of Alzheimer's disease. He is a member of the Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group. He is the Editor-in-chief of the World Journal of Neurology and the Associated Editor of the Journal of Alzheimer Disease.